Literature DB >> 9408096

Response of parkinsonian swallowing dysfunction to dopaminergic stimulation.

P C Hunter1, J Crameri, S Austin, M C Woodward, A J Hughes.   

Abstract

OBJECTIVES: To determine the degree of dopaminergic response of swallowing dysfunction in Parkinson's disease.
METHODS: Fifteen patients with idiopathic Parkinson's disease and symptomatic dysphagia were studied. All had motor fluctuations in response to long term levodopa therapy. On two separate days, after overnight withdrawal of all antiparkinsonian medication, a modified barium swallow using cinefluoroscopy and different food consistencies was performed before and after administration of oral levodopa and subcutaneous apomorphine.
RESULTS: Despite all patients having an unequivocal motor response to both agents, there were few significant responses in any of the quantitative or qualitative criteria of swallowing dysfunction assessed. The oral preparatory phase, generally considered a more voluntary component of swallowing, showed a response, but not with all consistencies. In a subgroup of patients the pharyngeal phase time also improved.
CONCLUSIONS: These findings suggest that parkinsonian swallowing dysfunction is not solely related to nigrostriatal dopamine deficiency and may be due to an additional non-dopamine related disturbance of the central pattern generator for swallowing in the pedunculopontine nucleus or related structures in the medulla.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9408096      PMCID: PMC2169826          DOI: 10.1136/jnnp.63.5.579

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  22 in total

1.  ALIMENTARY DISORDER IN PARKINSONISM.

Authors:  M J EADIE; J H TYRER
Journal:  Australas Ann Med       Date:  1965-02

2.  Editorial: Dysphagia in parkinsonism.

Authors:  J A Logemann; E R Blonsky; B Boshes
Journal:  JAMA       Date:  1975-01-06       Impact factor: 56.272

3.  Medullary and spinal efferents of the pedunculopontine tegmental nucleus and adjacent mesopontine tegmentum in the rat.

Authors:  D B Rye; H J Lee; C B Saper; B H Wainer
Journal:  J Comp Neurol       Date:  1988-03-15       Impact factor: 3.215

4.  Oesophageal dilatation in Parkinson's disease.

Authors:  F B Gibberd; J A Gleeson; A A Gossage; R S Wilson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-08       Impact factor: 10.154

5.  Some "minor" aspects of parkinsonism, especially pulmonary function.

Authors:  G D Paulson; R H Tafrate
Journal:  Neurology       Date:  1970-12       Impact factor: 9.910

6.  Overview of morphological changes in Parkinson's disease.

Authors:  K Jellinger
Journal:  Adv Neurol       Date:  1987

7.  Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease.

Authors:  S J Qualman; H M Haupt; P Yang; S R Hamilton
Journal:  Gastroenterology       Date:  1984-10       Impact factor: 22.682

8.  Neuromuscular disorders affecting the pharynx. Cineradiographic analysis.

Authors:  M L Silbiger; R Pikielney; M W Donner
Journal:  Invest Radiol       Date:  1967 Nov-Dec       Impact factor: 6.016

Review 9.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

10.  Swallowing and speech production in Parkinson's disease.

Authors:  J A Robbins; J A Logemann; H S Kirshner
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422

View more
  44 in total

1.  A translational approach to vocalization deficits and neural recovery after behavioral treatment in Parkinson disease.

Authors:  Michelle R Ciucci; Lisa Vinney; Emerald J Wahoske; Nadine P Connor
Journal:  J Commun Disord       Date:  2010-04-08       Impact factor: 2.288

2.  Treatment of dysautonomia in extrapyramidal disorders.

Authors:  Tjalf Ziemssen; Heinz Reichmann
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

Review 3.  Effects of therapy for dysphagia in Parkinson's disease: systematic review.

Authors:  Laura W J Baijens; Renée Speyer
Journal:  Dysphagia       Date:  2008-10-18       Impact factor: 3.438

4.  Assessing the role of dopamine in limb and cranial-oromotor control in a rat model of Parkinson's disease.

Authors:  Jacqueline R Kane; Michelle R Ciucci; Amber N Jacobs; Nathan Tews; John A Russell; Allison M Ahrens; Sean T Ma; Joshua M Britt; Lawrence K Cormack; Timothy Schallert
Journal:  J Commun Disord       Date:  2011-04-30       Impact factor: 2.288

5.  Alpha-Synuclein Pathology in Sensory Nerve Terminals of the Upper Aerodigestive Tract of Parkinson's Disease Patients.

Authors:  Liancai Mu; Jingming Chen; Stanislaw Sobotka; Themba Nyirenda; Brian Benson; Fiona Gupta; Ira Sanders; Charles H Adler; John N Caviness; Holly A Shill; Marwan Sabbagh; Johan E Samanta; Lucia I Sue; Thomas G Beach
Journal:  Dysphagia       Date:  2015-06-04       Impact factor: 3.438

Review 6.  Cortical afferent inhibition abnormalities reveal cholinergic dysfunction in Parkinson's disease: a reappraisal.

Authors:  Raffaele Nardone; Francesco Brigo; Viviana Versace; Yvonne Höller; Frediano Tezzon; Leopold Saltuari; Eugen Trinka; Luca Sebastianelli
Journal:  J Neural Transm (Vienna)       Date:  2017-08-12       Impact factor: 3.575

7.  Respiratory-swallowing coordination and swallowing safety in patients with Parkinson's disease.

Authors:  Michelle S Troche; Irene Huebner; John C Rosenbek; Michael S Okun; Christine M Sapienza
Journal:  Dysphagia       Date:  2010-07-11       Impact factor: 3.438

Review 8.  Treatment of dysautonomia in extrapyramidal disorders.

Authors:  Tjalf Ziemssen; Gerd Fuchs; Wolfgang Greulich; Heinz Reichmann; Michael Schwarz; Birgit Herting
Journal:  J Neurol       Date:  2011-05       Impact factor: 4.849

9.  Visuomotor control of neck surface electromyography in Parkinson's disease.

Authors:  Jessica R Malloy; Juliana C Valentin; Gabrielle L Hands; Christina A Stevens; Susan E Langmore; J Pieter Noordzij; Cara E Stepp
Journal:  NeuroRehabilitation       Date:  2014       Impact factor: 2.138

Review 10.  Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.

Authors:  Dirk Deleu; Yolande Hanssens; Margaret G Northway
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.